Olympus Co. (OTCMKTS:OLYMY – Get Free Report) saw a large drop in short interest in the month of May. As of May 29th, there was short interest totaling 39,080 shares, a drop of 39.6% from the May 14th total of 64,672 shares. Based on an average daily trading volume, of 185,604 shares, the short-interest ratio is currently 0.2 days.
Analyst Upgrades and Downgrades
Separately, The Goldman Sachs Group lowered Olympus from a “buy” rating to a “neutral” rating in a research note on Monday. One analyst has rated the stock with a Hold rating, According to data from MarketBeat, Olympus currently has an average rating of “Hold”.
Check Out Our Latest Research Report on Olympus
Olympus Price Performance
Olympus Company Profile
Olympus Corporation is a Tokyo-based manufacturer specializing in precision technology for the medical, scientific and industrial markets. Established in 1919, the company has built an international reputation for optical and digital imaging solutions that encompass endoscopic systems, microscopes, cameras and related accessories. Olympus leverages its expertise in optics, mechanics and electronics to develop instruments designed to advance diagnostics and scientific discovery.
In the healthcare sector, Olympus is best known for its endoscopy products and therapeutic solutions that support minimally invasive procedures in gastroenterology, pulmonology and urology.
Read More
- Five stocks we like better than Olympus
- Goldman’s S&P 500 Target Looks More Reachable After the Latest Rally
- 3 Stocks Diluting Shareholders to Fund Big Long-Term Opportunities
- Father’s Day Investing: 3 Stocks Built for Long-Term Returns
- This Golden Cross Could Send Urban Outfitters to New Highs
Receive News & Ratings for Olympus Daily - Enter your email address below to receive a concise daily summary of the latest news and analysts' ratings for Olympus and related companies with MarketBeat.com's FREE daily email newsletter.
